Not independent
Tenure on this board
5.0 yrs
7 nominees · 3 ballot items.
Three management proposals: (1) amend the Certificate of Incorporation to increase authorized common shares from 25,000,000 to up to 150,000,000 with Board discretion over the exact number and timing; (2) amend the Certificate of Incorporation to authorize a discretionary reverse stock split of common stock at a ratio between 1-for-2 and 1-for-20 to be effected by the Board within one year; and (3) authorize one or more adjournments of the Special Meeting to solicit additional proxies if necessary to approve Proposals 1 or 2.
Approve an amendment to the Company’s Certificate of Incorporation to increase authorized common shares from 25,000,000 to a number not to exceed 150,000,000, with the Board having discretion to select the specific number within that range and to file the amendment within one year of stockholder approval.
This management proposal seeks stockholder approval to amend the Certificate of Incorporation to expand the authorized common stock from 25,000,000 shares to up to 150,000,000 shares, with the Board authorized to determine the exact figure within that range and to file one or more Certificates of Amendment during the one-year authorization period. Management frames the request as necessary to satisfy approximately 32.7 million reserved shares for options, warrants, equity awards and convertible securities and to avoid potential breaches of contractual share reservation covenants that could trigger defaults. The Board emphasizes flexibility: rather than authorizing the maximum immediately (which would increase Delaware franchise taxes), it requests a range so it can set the appropriate authorized level when needed. The proposal will permit the Company to issue equity for financings, strategic transactions, and to continue equity-based compensation programs, but it will also increase the pool of authorized but unissued shares that could be dilutive to existing holders. The filing describes potential anti-takeover effects and disclaims any intent to use the authorization to entrench management, while acknowledging that additional authorized shares could be used in ways that make a takeover more difficult. Implementation mechanics allow the Board to file multiple amendments within the one-year window, or to abandon filings if circumstances change, which provides management operational flexibility but reduces near-term stockholder control over future increases. Given the Company’s current shortfall between authorized shares and reservation obligations, the Board argues the increase is prudent to avoid contractual breaches and to preserve access to capital; the Board unanimously recommends a vote FOR and ties the recommendation to these operational and compliance rationales. The principal risks are dilution and potential anti-takeover uses of the newly authorized capacity; therefore, shareholders should weigh the immediate contractual/compliance need against longer-term dilution risk and governance considerations.
Approve an amendment to the Certificate of Incorporation authorizing the Board to effect, within one year, a single reverse stock split of common stock at a ratio selected by the Board between 1-for-2 and 1-for-20, primarily to regain or maintain compliance with Nasdaq's $1.00 minimum bid price requirement.
This management proposal seeks shareholder authorization to allow the Board to implement a single reverse stock split at a ratio between 1-for-2 and 1-for-20 during the one-year authorization period, with the principal stated purpose of increasing the per-share trading price to regain and maintain compliance with Nasdaq’s $1.00 minimum bid price rule. The Company received a Nasdaq deficiency notice for failing to maintain the minimum bid price and faces a Compliance Deadline; the Board views a reverse split as a practical tool to elevate the trading price quickly if market-driven recovery is insufficient. The proposal confers substantial discretion to the Board over whether to effect the split, the exact ratio within the approved range, and the timing, allowing management to tailor the action to prevailing market conditions and capital needs. The filing outlines additional potential benefits (improved institutional investor interest, marketability, and liquidity) but appropriately cautions there is no guarantee the split will achieve sustained compliance or proportional price increase. The split will reduce the number of outstanding shares, adjust equity awards and convertible instruments proportionately, and—unusually here—round fractional shares up to the nearest whole share, slightly increasing outstanding share count compared to a strict mathematical split; this fractional treatment could modestly dilute existing holders. Because implementation increases authorized-but-unissued shares relative to outstanding shares, the reverse split could make future dilution easier, especially if combined with Proposal 1’s authorized-share increase. The Board unanimously recommends FOR the proposal as a defensive compliance and market-structure tool; evaluation should consider the trade-off between short-term Nasdaq compliance potential and longer-term dilution/governance implications, as well as market reaction uncertainties.
Authorize the holders of proxies to adjourn the Special Meeting one or more times, if necessary or appropriate, to solicit additional proxies to obtain sufficient votes to approve Proposal 1 and/or Proposal 2.
The adjournment proposal asks shareholders to grant the proxy holders authority to adjourn the Special Meeting if there are insufficient votes to approve the Authorized Share Increase or the Reverse Stock Split, enabling further solicitation of proxies. Management frames this as a customary and pragmatic measure to avoid wasting resources by concluding a meeting without sufficient votes and to provide additional time to communicate with and solicit votes from shareholders who may be undecided or unreachable before the scheduled meeting. A vote FOR effectively gives the Board procedural flexibility to continue solicitations without having to call a new special meeting; a vote AGAINST would limit that procedural option and could force the Company to accept the vote outcome at the scheduled meeting or to pursue alternative, potentially more costly, approaches. The proposal requires a majority of votes cast to pass, and broker non-votes do not affect its outcome, reducing the risk of procedural failure due to street-name voting. While routine, the adjournment proposal can have material practical consequences if Proposals 1 or 2 are close or controversial, because additional solicitation time can change outcomes. The Board unanimously recommends FOR; shareholders should view this as neutral governance dilution-wise but influential on the process and timing of any approval of the other substantive proposals.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.87% | 85,140 | $43K |
| 2 | Virtu Financial LLC | 0.81% | 79,128 | $40K |
| 3 | HRT FINANCIAL LP | 0.71% | 69,485 | $35K |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.69% | 67,416 | $34K |
| 5 | MORGAN STANLEY | 0.56% | 54,980 | $28K |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 0.50% | 48,920 | $25K |
| 7 | CITADEL ADVISORS LLC | 0.42% | 40,976 | $21K |
| 8 | VANGUARD FIDUCIARY TRUST CO | 0.35% | 34,040 | $17K |
| 9 | UBS Group AG | 0.25% | 24,733 | $12K |
| 10 | JANE STREET GROUP, LLC | 0.19% | 18,678 | $9K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.